Nan Fung Group Holdings LTD Kymera Therapeutics, Inc. Transaction History
Nan Fung Group Holdings LTD
- $103 Million
- Q3 2024
A detailed history of Nan Fung Group Holdings LTD transactions in Kymera Therapeutics, Inc. stock. As of the latest transaction made, Nan Fung Group Holdings LTD holds 10,875 shares of KYMR stock, worth $436,196. This represents 0.5% of its overall portfolio holdings.
Number of Shares
10,875
Previous 10,875
-0.0%
Holding current value
$436,196
Previous $324,000
58.64%
% of portfolio
0.5%
Previous 0.38%
Shares
3 transactions
Others Institutions Holding KYMR
# of Institutions
184Shares Held
64.4MCall Options Held
50.6KPut Options Held
81.7K-
Price T Rowe Associates Inc Baltimore, MD6.65MShares$267 Million0.04% of portfolio
-
Baker Bros. Advisors LP New York, NY6MShares$240 Million3.04% of portfolio
-
Bvf Inc San Francisco, CA5.16MShares$207 Million7.77% of portfolio
-
Atlas Venture Life Science Advisors, LLC4.9MShares$196 Million28.59% of portfolio
-
Vanguard Group Inc Valley Forge, PA4.75MShares$191 Million0.0% of portfolio
About Kymera Therapeutics, Inc.
- Ticker KYMR
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 54,705,800
- Market Cap $2.19B
- Description
- Kymera Therapeutics, Inc., a biopharmaceutical company, focuses on discovering and developing novel small molecule therapeutics that selectively degrade disease-causing proteins by harnessing the body's own natural protein degradation system. It engages in developing IRAK4 program, which is in Phase I clinical trial for the treatment of immunolo...